Lekhansh Shukla, MD, DM

  • 4Articles
  • 20.2KReads1
  • 2017–2024Active
  • 15Collaborators
  • 21Citations2

1 Read counts for articles published before 2020 may include some non-human traffic.

2 Citation counts provided by Crossref.

About

Lekhansh Shukla, MD, DM, is affiliated with the Centre for Addiction Medicine, Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, India. Shukla has published research on addiction, panic disorder, and schizophrenia/schizoaffective disorders, focusing on topics such as substance-related hallucinations, complications of disulfiram-ethanol reactions, alcohol dependence and associated movement disorders, and benzodiazepine and Z-drug dependence. Contributions span from 2017 to 2024 in Psychiatrist.com (The Journal of Clinical Psychiatry and The Primary Care Companion for CNS Disorders). Frequent collaborators include Jayant Mahadevan, Pratima Murthy, Abhishek Khatri, Arun Kandasamy, and Ateev Sudhir Chandna.

Publications

PCC
Hallucinations Following IV Tapentadol Use
Case Report

Hallucinations Following IV Tapentadol Use

July 23, 2024

The authors describe 2 cases of individuals who developed tapentadol-induced hallucinations in clear consciousness following nonprescribed intravenous use.
, , , et al
PCC
Case Report

Disulfiram-Ethanol Reaction and Cerebral Infarction

April 16, 2020

Here, read about 2 cases of disulfiram-ethanol reaction leading to watershed area infarct in both patients and probable ischemia in one. These cases emphasize the need for rigorous patient...
, , , et al
PCC
Letter to the Editor

Alcohol and Neuroglycopenia

January 3, 2019

With all the sugar in alcohol, you' d think it would only raise blood sugar. But in these 2 patients, because of an accompanying complex of distressed internal symptoms,...
, , , et al
PCC
Brief Report

Benzodiazepine and "Z-Drug" Dependence

February 16, 2017

Benzodiazepine and Z-drug dependence are frequently comorbid with other substance use and psychiatric disorders. Read this brief report to gain a greater understanding of the clinical characteristics and course...
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Ketamine and Psychedelics

Listen to the Podcast
The Journal of Clinical Psychiatry podcast cover with Benjamin Brody, MD

Subscribe to read
more articles

Subscribe